Literature DB >> 33343833

Trauma exposure therapy in a pregnant woman suffering from complex posttraumatic stress disorder after childhood sexual abuse: risk or benefit?

Julia Becker-Sadzio1, Friederike Gundel1, Agnes Kroczek1, Stefanie Wekenmann1, Alexander Rapp2, Andreas J Fallgatter1, Saskia Deppermann1.   

Abstract

Background: Mental disorders during pregnancy are common and affect the health of mother and child. Despite a relatively high prevalence rate, treatment options have not been investigated systematically. Particularly symptoms of posttraumatic stress disorder (PTSD) may increase significantly during the course of pregnancy. However, proper guidelines for psychotherapeutic treatment of PTSD during pregnancy do not exist. Objective: In this article, we aimed at discussing the effects of untreated PTSD on pregnancy and postpartum mother-child bonding as well as exposure therapy during pregnancy. Method: To do so, we present the case of a pregnant woman with complex PTSD following childhood sexual abuse. At the time of hospitalization, the patient was pregnant in the second trimester and reported intrusive re-experiencing of the traumatic events, nightmares, anxiety and helplessness as well as an impairing level of irritability during social situations. After a careful discussion of the case within our department and at the annual conference of the German Association of Psychiatry, Psychotherapy and Psychosomatics, we decided to treat the patient with dialectical behavior therapy for PTSD (DBT-PTSD) including exposure therapy under the regular observation of a gynecologist. Psychometric measurements (Davidson Trauma Scale (DTS) and Borderline Symptom- List-23 (BSL-23) were used to observe the course of treatment regarding common PTSD-symptoms and disturbances in self-organization (DSO).
Results: The intensity of intrusions and hyperarousal increased from the date of admission, reached the maximum when exposure started and decreased below baseline-level at the end of treatment. Avoidance behavior continually decreased from the beginning until the end of therapy. Decreased BSL-23 values show major improvements regarding DSO. To our knowledge, the course of pregnancy was not affected by treatment-induced psychological and physical symptoms.Conclusions: DBT- PTSD is a potential treatment option for patients suffering from PTSD during pregnancy. Yet, further (epigenetic) research in this field is urgently needed.
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Trauma exposure therapy during pregnancy; complex posttraumatic stress disorder; transgenerational effects of PTSD; trauma focused dialectical behaviour therapy; treatment-induced transgenerational effects

Year:  2020        PMID: 33343833      PMCID: PMC7734094          DOI: 10.1080/20008198.2019.1697581

Source DB:  PubMed          Journal:  Eur J Psychotraumatol        ISSN: 2000-8066


Introduction

To date, despite a relatively high prevalence rate, the treatment of mental disorders during pregnancy, which presumably affect the health of both mother and child, has not been investigated systematically (Costa, Souza, Pedroso, & Strufaldi, 2018; Jha, Salve, Goswami, Sagar, & Kant, 2018). Women with risk factors, such as previous mental disorders or an increased number of stressful or traumatic life experiences, are at particular risk to develop psychiatric symptoms during pregnancy (Vesga-Lopez et al., 2008). Onoye et al. (2013) investigated longitudinal changes in mental health during pregnancy and found that while depression and anxiety symptoms remained stable over the course of pregnancy, general stress and symptoms of Posttraumatic stress disorder (PTSD) increased significantly during the third trimester. Furthermore, maternal mental illness and associated factors of psychological distress during pregnancy are linked to serious effects on child development including preterm birth and low birth weight (Schetter & Tanner, 2012). Moreover, symptoms of untreated PTSD present a high risk factor for postpartum depression and are likely to impair mother-child bonding. Impaired postpartum bonding has been shown to be related to severe deficits regarding the socioemotional development of the child and hence increase the vulnerability to develop psychiatric disorders later on in life. Interestingly, there are hints that mental illnesses which relate to unresolved childhood trauma of the mother herself seem to have the highest impact on disturbed dyadic interaction after delivery and, accordingly, the attachment style of the child (Dubber, Reck, Muller, & Gawlik, 2015). Moreover, there is evidence that mothers with untreated difficulties in emotion regulation, present a risk factor for neglect as well as physical and sexual abuse in their own children (Clemens, Berthold, Fegert, & Kolch, 2018). There are in fact hints that the transgenerational effects of traumatization even include biomolecular changes. There is, for example, discrete evidence that consequences of traumatization have an outlasting effect on the next generation in terms of transgenerational epigenetic transmission by means of differentiated DNA methylation (Mulligan, D’Errico, Stees, & Hughes, 2012; Perroud et al., 2014). Despite these findings and a high prevalence rate of PTSD (Khoramroudi, 2018), proper guidelines for psychotherapeutic treatment during pregnancy do not exist. For example, the German S3-Guidelines merely state that stabilization techniques are to be given preference (Flatten et al., 2011). Surely, exposure-based treatments are associated with increased stress and initial worsening of symptoms during the course of treatment (American Psychological Association, 2017; Flatten et al., 2011), but further details are lacking regarding the circumstances under which it might still be beneficial to implement exposure-based treatment methods or whether there are critical time periods during pregnancy with respect to child development. In this context, the investigation of a treatment approach for PTSD during pregnancy seems of high relevance. Here, the authors present the case of a pregnant woman suffering from complex PTSD (cPTSD) after childhood sexual abuse (CSA) who underwent a 12-week exposure-based dialectical behaviour therapy for PTSD (DBT-PTSD) (Bohus, Dyer, et al., 2013) at the University Hospital of Tuebingen. Effects of PTSD symptoms on the mental and physical health of mother and child during pregnancy and the consequences of exposure-based treatments are discussed.

Case presentation and methods

Mrs S. was a 25-year-old married Caucasian woman when she presented herself the first time to us at the clinic’s trauma consultation centre for a preliminary examination, without previous psychotherapeutic treatment. The pregnant woman (13th week of gestation) already had a two-year-old daughter. At the time of hospitalization, Mrs S. was pregnant in the 21st week of pregnancy. She had suffered from symptoms like intrusions, nightmares and irritability in social situations for a long time following CSA by a close relative between the age of five and ten as well as a substantial emotional neglect by her mother. Furthermore, she showed distinct avoidance behaviour in an effort to try to maintain a minimum of emotional stability and functionality. Her initial childhood traumatic experiences were reactivated when an unknown person touched her from behind about two months ago. As she was worried about being unable to take appropriate care of her two children after the birth of the second one, she requested cue-exposure therapy before delivery. During a careful examination, we found that she fulfilled the criteria for cPTSD according to ICD-11 (international classification of diseases 11th revision; 1) (Maercker, Brewin, Bryant, Cloitre, Reed, et al., 2013; Maercker, Brewin, Bryant, Cloitre, van Ommeren, et al., 2013; Maercker, Hecker, Augsburger, & Kliem, 2018). In ICD-11, the diagnosis of cPTSD is defined by disturbances in self-organization (DSO) by means of affective dysregulation, impulsivity and negative self-concept as well as disturbances in relationships to others in addition to the classical PTSD symptom cluster (Karatzias et al., 2017). In this regard, particularly overwhelming, long-lasting, reoccurring traumatic experiences during childhood, such as sexual abuse, are considered a risk factor for the development of cPTSD (de Aquino Ferreira, Queiroz Pereira, Neri Benevides, & Aguiar Melo, 2018). Besides the core criteria of PTSD, DSO were seen through difficulties in appropriate regulation of trauma-related emotions such as anxiety, anger and intense feelings of helplessness, as well as an increased and impairing level of fear and irritability in social situations. The sexual relationship with her husband was severely impaired. Furthermore, the patient was burdened by her negative self-concept as a bad mother. Apart from the cPTSD diagnosis, she did not fulfil the complete criteria for any other mental disorder. In advance of the in-patient admission to our 12-week exposure-based DBT-PTSD program (Bohus, Dyer, et al., 2013), her gynaecologist was consulted and an individual risk-benefit-assessment was conducted (for more details please refer to the discussion). Mrs S. started her treatment when she was pregnant during the second trimester (21st week of pregnancy). Her gynaecologist routinely observed the course of pregnancy during the whole course of the treatment without reporting any serious adverse events. Psychometric measurements Davidson Trauma Scale (DTS) and Borderline Symptom-List-23 (BSL-23) were used to observe the course of treatment regarding common PTSD-symptoms and DSO. The Davidson Trauma Scale (DTS) is a 17-Item self-rating scale with a good internal as well as retest reliability and validity, measuring PTSD symptom severity in terms of trauma-related re-experiencing, avoidance behaviour and hyperarousal (Davidson et al., 1997). For the single items, scores between 0 and 1 point to asymptomatic or low symptom severity, scores around 2 point to moderate symptom severity and scores between 3 and 4 to high or very high symptom severity. Further, the test retest reliability is reported to be r = 0.86. According to Davidson, Tharwani, & Connor (2002), the distribution in a normative general population has been found to be at mean (SD) = 11.0 (18.1). Statistically reliable changes regarding symptom improvement over the time course of therapy were examined by means of the reliable change index (RCI) as suggested by, for example, Jacobson & Truax, (1991). Thus RCI was calculated using the reported test-retest reliability as well as the SD of the normative population as whereby represented the total sum score of the DTS at the beginning of treatment (week of pregnancy 21) and represented the total sum score at the end of treatment (week of pregnancy 31). According to Jacobson, the cut-off value for RCI was set to 1.96. The BSL-23 is also a self-rating instrument, with a range from 0 (symptoms absent) to 4 (symptoms clearly present), examining symptoms, which are typically increased in patients with Borderline personality disorder (BPD) such as emotional dysregulation, and negative thoughts and feelings about oneself and others (Bohus, Limberger, et al., 2007), and was therefore used to assess DSO-related impairments. For BPD patients, the average score is known to be around mean (SD) = 2 (0.76), whereas healthy controls score around mean (SD) = 0.4 (0.22). Again, the internal as well as retest reliability has been judged as high (Bohus, Limberger, et al., 2007). Furthermore, the change-sensitivity has been rated as highly significant (p < 0.0001) (Wolf et al., 2009). To address a particular group of patients suffering from core PTSD symptoms and severe impairments of DSO, DBT-PTSD was developed (Bohus, Dyer, et al., 2013). This treatment option is based on the dialectical principles of standard DBT focussing on mindfulness, distress tolerance, emotion regulation and interpersonal effectiveness (Linehan et al., 2015). Seven treatment phases characterize DBT-PTSD (commitment, trauma-model and motivation, skills and cognitive elements, skills-assisted exposure, radical acceptance, a life worth living, and farewell) (Bohus, Dyer, 2013; Bohus et al., 2019). The essential difference between DBT-PTSD and the standard Prolonged Exposure Protocol (Harned, Korslund, Foa, & Linehan, 2012; Harned, Korslund, & Linehan, 2014), is that exposure sessions are conducted in a skills-assisted manner in order to prevent dissociative symptoms during exposure. This takes account of the finding that state dissociation during psychotherapeutic interventions is accompanied with reduced treatment outcomes (Kleindienst et al., 2016). During the first treatment period (weeks 1–3), individual psychotherapeutic goals of Mrs S. were derived from a problem analysis (1. reduction of avoidance behaviour and escape strategies by means of trauma-confrontation, 2. improvement of abilities to distance herself from others, 3. improvement of sexuality) and Mrs S. learned how to use distress tolerance skills effectively to prepare herself for the exposure treatment. During the second period (weeks 4–9), a graded exposure-based treatment started at the beginning of the 24th week of pregnancy. In our case, the skills-assisted exposure took place in two therapist-guided sessions per week followed by self-management sessions (3 sessions/week), during which the patient repeatedly listened to recordings of the therapist-guided in sensu exposure sessions. In order to prevent dissociative symptoms during self-administered exposure, the computer program Morpheus was applied. Morpheus continuously monitors the level of dissociative states and offers state-related antidissociative skills (Gorg et al., 2016). In addition to exposure, Mrs S. worked on distancing herself from her mother and practiced self-care skills. The last treatment period focused on the transfer from the clinical setting to everyday life.

Treatment results

The baseline DTS score pointed to a moderate symptom severity regarding PTSD symptoms at the time of hospitalization. Looking at the course of treatment (see Table 1), PTSD symptoms, particularly the intensity of intrusions and hyperarousal, increased from the date of admission, reached the maximum when exposure started around the 24th week of pregnancy and decreased below baseline-level at the end of treatment. In contrast, avoidance behaviour continually decreased from the date of admission until the end of therapy. Regarding statistically reliable changes, we found the RCI for the total DTS sum scores to be at RCI = 2.09 ≥ 1.96.
Table 1.

Treatment results regarding PTSD core symptoms and disturbances in self-organization (DSO)

 Davidson trauma scale
 
 Frequency
Intensity
Frequency
Intensity
DSO
Week of PregnancyIntrusionsAvoidance behaviour and emotional numbingHyperarousalIntrusionsAvoidance behaviour and emotional numbingHyperarousalTotal scaleTotal scaleBSL-23
21914101016833341.87
2399111491129341.87
269101114101130350.78
299971410825320.56
31861097724231
6 Month after Birth87896723221.04
Treatment results regarding PTSD core symptoms and disturbances in self-organization (DSO) Decreased values in the BSL-23 show major improvements regarding DSO. In summary, an improvement of psychosocial functioning due to a decreased level of PTSD-related symptoms was observed. The 6-month catamnesis revealed a stable reduction of intrusive symptoms, whereas the frequency of avoidance behaviour modestly increased again. BSL-23 values also remained stable 6 month after birth. For a better overview, Table 1 represents the raw scores of all (sub-) scales over the treatment periods. The course of pregnancy was not affected by treatment-induced psychological and physical symptoms and our patient gave birth to a healthy boy.

Discussion

Even though PTSD is common in pregnant women (Khoramroudi, 2018) and affects the health of both mother and child, there is a lack of evidence on (exposure-based) treatment methods during pregnancy. Before including Mrs S. into our DBT-PTSD program, we performed a careful risk-benefit-assessment and considered previous findings regarding the course of mental disorders during pregnancy. For example, a previous study could show that general stress and, in particular, PTSD-symptoms, increased during the third trimester of pregnancy (Onoye et al., 2013). Further analysis of the subcategories ‘re-experiencing’, ‘avoidance’ and ‘arousal’ showed that this increase in symptom severity was mainly due to the subcategory ‘re-experiencing’. One essential goal of exposure-based treatment options is to reduce precisely this category of symptoms and without disorder-specific psychotherapeutic interventions, a worsening of Mrs S. PTSD symptoms during the course of pregnancy could have been expected. In light of these findings, it seems especially interesting that we found the opposite effect in terms of a stable reduction of intrusive symptoms after 12-week DBT-PTSD, which can be associated with the chosen exposure-based treatment option. On the other hand, it must be kept in mind that exposure-based treatment is commonly linked to initial worsening of symptoms, which was observed by us as well and might be considered an actualization of the traumatic event. In this context, the increase in intrusions and hyperarousal may further be seen as a result of the reduction of avoidance behaviour, which was observed at the same time. When discussing the consequences of psychological stress and PTSD during pregnancy, biomolecular transgenerational effects should also be taken into account. Perroud et al. (2014) showed that DNA methylation modifications in pregnant mothers suffering from PTSD were inheritable by their children and associated with lower cortisol levels. Mulligan et al. (2012) related prenatal maternal stress to increased DNA methylation levels of the premotor region of the NR3C1 glucocorticoid receptor in their offspring, which might result in an increased stress reactivity, and thus presents a risk factor for chronic diseases. Due to a number of limitations, such as small sample sizes and uncontrollable confounding factors, the results mentioned above provide only limited trendsetting impetus with respect to treatment-associated decision-making, but should certainly be taken into consideration. Regarding our case, Mrs S. was not only suffering from unspecific symptoms due to CSA, but further reported pronounced PTSD symptoms like continual re-experiencing of traumatic experiences and avoidance of trauma-related stimuli. In light of the described effects of CSA on motherhood, the benefit of a trauma-specific treatment approach outweighed possible epigenetic effects due to an increase in psychological distress at the beginning of the exposure sessions. A crucial point for the decision was the subjective impairment by Mrs S. PTSD symptoms, which resulted in a constantly increased stress level and was thus considered a risk factor, not only for impaired postpartum mother-child bonding but also epigenetic changes due to the symptom-induced stress. When having the option, it is certainly more desirable to treat PTSD symptoms prior to pregnancy. However, as this is not always possible it is important to carefully consider the consequences of untreated PTSD on the course of pregnancy but also on the dyadic mother-child interaction right after birth. In cases where symptom severity is less pronounced, it might still be more beneficial to confine the treatment to the mere application of stabilizing techniques. Within this framework, it might further be advisable to specifically prepare mothers suffering from cPTSD for the situation after delivery to prevent postpartum depression as well as impaired bonding. To date and to our knowledge, there are no conclusive studies investigating exposure-based trauma therapy during pregnancy. Thus, our case report presents the first scientific attempt addressing this topic. Still, there are a number of limitations which need to be mentioned: on the one hand, we have no discrete information on the frequency as well as the severity of the cPTSD symptoms by means of BSL or DTS scores prior to the admittance to our clinic. Thus, we cannot exclude that the inclusion to our treatment program already had an effect on the manifestation of Mrs S.’ symptoms. Another critical limitation is the fact that we exclusively used self-administered measurements to assess the extent of symptoms. Especially considering that we merely collected the data of one patient, we could have added more validity by additionally implementing clinician-administered measurements. Furthermore, regarding our catamnesis, we merely collected data regarding Mrs S. herself, but have no information on the child with regard to mother-child-bonding or the post-partum development. Considering the study by Onoye et al. (2013), which found out that PTSD symptoms often increase during the third trimester, it would have been interesting to put more focus on Mrs S. first pregnancy in order to find out if she indeed experienced an increase in symptom severity during the course of it. This way, we would have been able to compare the course of her first pregnancy without treatment and her second pregnancy with treatment as well as the relating post-partum periods at least with regards to her subjective experience. On a related note, her subjective experience in terms of external study validity going beyond the collected questionnaire data could have been taken more into account and might have added interesting hints on the relevancy to everyday life after she was discharged from our clinic. Further, in order to weigh the potential risks and benefits of the chosen treatment, it would have been helpful to implement objective distress ratings such as heart rate and cortisol levels before, after and during the course of exposure. Finally, it is not possible to draw strong and generalizable conclusions from a single case report. Still, in our particular case, we can confirm that DBT-PTSD is a potential psychotherapeutic treatment option for patients suffering from cPTSD during pregnancy. In this regard, we still found a statistically reliable decrease in symptom severity when relating the changes in symptom severity of our patient to the respective statistical parameters of a general normative population. Thus the treatment results may be seen as a chance to interrupt transgenerational repetitions of dysfunctional family patterns. Looking at trauma-specific scores as represented by the DTS in more detail on the different subscales, intensity as well as frequency decreased from moderate to low, whereby the most striking effect was found on avoidance behaviour and emotional numbing. Even though the effects on intrusions were rather small, it needs to be kept in mind that in untreated PTSD, intrusions commonly increase during pregnancy, supposedly masking the impact of our intervention. Further, DSO decreased by more than a standard deviation with regards to the distribution typically found in BPD patients. In order to allow a more generalizable assessment, further research in the form of randomized controlled trials would be desirable, yet hard to realize. There is one randomized controlled study (Baas, Stramrood, Dijksman, de Jongh, & van Pampus, 2017), which currently examines eye-movement desensitization and reprocessing (EMDR) therapy as an exposure-based treatment approach during pregnancy in patients with childbirth-associated PTSD and fear of birth. Even though the results will certainly be interesting and may help to make a decision on how to treat pregnant women suffering from PTSD, epigenetic aspects are not considered. Thus, additional case-control studies are needed to investigate transgenerational effects in terms of epigenetic changes in mothers and their children with regard to long-term child development.
  28 in total

1.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

Review 2.  Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice.

Authors:  Christine Dunkel Schetter; Lynlee Tanner
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

3.  Changes in PTSD symptomatology and mental health during pregnancy and postpartum.

Authors:  Jane M Onoye; Leigh Anne Shafer; Deborah A Goebert; Leslie A Morland; Courtenay R Matsu; Fumiaki Hamagami
Journal:  Arch Womens Ment Health       Date:  2013-12       Impact factor: 3.633

Review 4.  [Children of mentally ill parents : Also a topic in the context of child protection].

Authors:  V Clemens; O Berthold; J M Fegert; M Kölch
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

5.  Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial.

Authors:  Martin Bohus; Anne S Dyer; Kathlen Priebe; Antje Krüger; Nikolaus Kleindienst; Christian Schmahl; Inga Niedtfeld; Regina Steil
Journal:  Psychother Psychosom       Date:  2013-05-22       Impact factor: 17.659

6.  ICD-11 Prevalence Rates of Posttraumatic Stress Disorder and Complex Posttraumatic Stress Disorder in a German Nationwide Sample.

Authors:  Andreas Maercker; Tobias Hecker; Mareike Augsburger; Sören Kliem
Journal:  J Nerv Ment Dis       Date:  2018-04       Impact factor: 2.254

7.  Psychiatric disorders in pregnant and postpartum women in the United States.

Authors:  Oriana Vesga-López; Carlos Blanco; Katherine Keyes; Mark Olfson; Bridget F Grant; Deborah S Hasin
Journal:  Arch Gen Psychiatry       Date:  2008-07

8.  Burden of common mental disorders among pregnant women: A systematic review.

Authors:  Shreya Jha; Harshal R Salve; Kiran Goswami; Rajesh Sagar; Shashi Kant
Journal:  Asian J Psychiatr       Date:  2018-06-28

9.  The OptiMUM-study: EMDR therapy in pregnant women with posttraumatic stress disorder after previous childbirth and pregnant women with fear of childbirth: design of a multicentre randomized controlled trial.

Authors:  M A M Baas; C A I Stramrood; L M Dijksman; A de Jongh; M G van Pampus
Journal:  Eur J Psychotraumatol       Date:  2017-02-24

10.  PTSD and Complex PTSD: ICD-11 updates on concept and measurement in the UK, USA, Germany and Lithuania.

Authors:  Thanos Karatzias; Marylene Cloitre; Andreas Maercker; Evaldas Kazlauskas; Mark Shevlin; Philip Hyland; Jonathan I Bisson; Neil P Roberts; Chris R Brewin
Journal:  Eur J Psychotraumatol       Date:  2018-01-15
View more
  1 in total

1.  Understanding links between maternal perinatal posttraumatic stress symptoms and infant socioemotional and physical health.

Authors:  Lindsay Huffhines; Jesse L Coe; Alex Busuito; Ronald Seifer; Stephanie H Parade
Journal:  Infant Ment Health J       Date:  2022-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.